Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia.

Evidente VG, Fernandez HH, LeDoux MS, Brashear A, Grafe S, Hanschmann A, Comella CL.

J Neural Transm. 2013 Dec;120(12):1699-707. doi: 10.1007/s00702-013-1048-3. Epub 2013 Jun 19.

PMID:
23779062
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm.

Truong DD, Gollomp SM, Jankovic J, LeWitt PA, Marx M, Hanschmann A, Fernandez HH; Xeomin US Blepharospasm Study Group.

J Neural Transm. 2013 Sep;120(9):1345-53. doi: 10.1007/s00702-013-0998-9. Epub 2013 Feb 23.

PMID:
23435927
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.

Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S; U.S. XEOMIN Cervical Dystonia Study Group.

J Neurol Sci. 2011 Sep 15;308(1-2):103-9. doi: 10.1016/j.jns.2011.05.041. Epub 2011 Jul 18.

PMID:
21764407
[PubMed - indexed for MEDLINE]
4.

Long-term efficacy and safety of incobotulinumtoxinA injections in patients with cervical dystonia.

Dressler D, Paus S, Seitzinger A, Gebhardt B, Kupsch A.

J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):1014-9. doi: 10.1136/jnnp-2012-303608. Epub 2013 May 18.

PMID:
23687362
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Botulinum toxin type B for cervical dystonia.

Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004315. Review.

PMID:
15674941
[PubMed - indexed for MEDLINE]
6.

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.

Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S; Global Dysport Cervical Dystonia Study Group.

Parkinsonism Relat Disord. 2010 Jun;16(5):316-23. doi: 10.1016/j.parkreldis.2010.03.002. Epub 2010 Mar 31.

PMID:
20359934
[PubMed - indexed for MEDLINE]
7.

AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies.

Hauser RA, Truong D, Hubble J, Coleman C, Beffy JL, Chang S, Picaut P.

J Neural Transm. 2013 Feb;120(2):299-307. doi: 10.1007/s00702-012-0872-1. Epub 2012 Aug 10.

PMID:
22878514
[PubMed - indexed for MEDLINE]
8.

Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.

Jankovic J, Comella C, Hanschmann A, Grafe S.

Mov Disord. 2011 Jul;26(8):1521-8. doi: 10.1002/mds.23658. Epub 2011 Apr 22.

PMID:
21520284
[PubMed - indexed for MEDLINE]
9.

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M.

Neurology. 1999 Oct 22;53(7):1439-46.

PMID:
10534248
[PubMed - indexed for MEDLINE]
10.

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.

Pappert EJ, Germanson T; Myobloc/Neurobloc European Cervical Dystonia Study Group.

Mov Disord. 2008 Mar 15;23(4):510-7.

PMID:
18098274
[PubMed - indexed for MEDLINE]
11.

A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.

Quagliato EM, Carelli EF, Viana MA.

Clin Neuropharmacol. 2010 Jan-Feb;33(1):22-6. doi: 10.1097/WNF.0b013e3181c46f48.

PMID:
19959960
[PubMed - indexed for MEDLINE]
12.

Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical Dystonia.

Fernandez HH, Pappert EJ, Comella CL, Evidente VG, Truong DD, Verma A, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2013 Apr 18;3. pii: tre-03-140-2921-1. Print 2013.

PMID:
23610743
[PubMed]
Free PMC Article
13.

[A double-blind comparative study to evaluate the efficacy and safety of NerBloc® (rimabotulinumtoxinB) administered in a single dose to patients with cervical dystonia].

Kaji R, Shimizu H, Takase T, Osawa M, Yanagisawa N.

Brain Nerve. 2013 Feb;65(2):203-11. Japanese.

PMID:
23399677
[PubMed - indexed for MEDLINE]
14.

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.

Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD.

Neurology. 1997 Sep;49(3):701-7.

PMID:
9305326
[PubMed - indexed for MEDLINE]
15.

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.

Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M.

Neurology. 1999 Oct 22;53(7):1431-8.

PMID:
10534247
[PubMed - indexed for MEDLINE]
16.

Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.

Winner PK, Sadowsky CH, Martinez WC, Zuniga JA, Poulette A.

Headache. 2012 Sep;52(8):1219-25. doi: 10.1111/j.1526-4610.2012.02164.x. Epub 2012 May 18.

PMID:
22607530
[PubMed - indexed for MEDLINE]
17.

IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated.

Evidente VG, Truong D, Jankovic J, Comella CL, Grafe S, Hanschmann A.

J Neurol Sci. 2014 Aug 10. pii: S0022-510X(14)00517-6. doi: 10.1016/j.jns.2014.08.004. [Epub ahead of print]

PMID:
25186131
[PubMed - as supplied by publisher]
18.

A guide to dosing in the treatment of cervical dystonia and blepharospasm with Xeomin®: a new botulinum neurotoxin A.

Pagan FL, Harrison A.

Parkinsonism Relat Disord. 2012 Jun;18(5):441-5. doi: 10.1016/j.parkreldis.2012.02.008. Epub 2012 Mar 9. Review.

PMID:
22405829
[PubMed - indexed for MEDLINE]
19.

Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study.

Laubis-Herrmann U, Fries K, Topka H.

Eur Neurol. 2002;47(4):214-21.

PMID:
12037435
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.

Figgitt DP, Noble S.

Drugs. 2002;62(4):705-22. Review.

PMID:
11893235
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk